Abstract:Ubiquitin-like proteins (UBLs) constitute a family of evolutionarily conserved proteins that share similarities with ubiquitin in 3D structures and modification mechanisms. For most UBLs including Small-Ubiquitin-like Modifiers (SUMO), their modification sites on substrate proteins cannot be identified using the mass spectrometry-based method that has been successful for identifying ubiquitination sites, unless a UBL protein is mutated accordingly. To identify UBL modification sites without having to mutate UBL, we have developed a dedicated search engine pLink-UBL on the basis of pLink, a software tool for identification of cross-linked peptide pairs. pLink-UBL exhibited superior precision, sensitivity, and speed than make-do search engines such as MaxQuant, pFind, and pLink. For example, compared to MaxQuant, pLink-UBL increased the number of identified SUMOylation sites by 50 ~ 300% from the same datasets. Additionally, we present a method for identifying small-molecule modifications of UBLs. This method involves antibody enrichment of a UBL C-terminal peptide following enrichment of a UBL protein, followed by LC-MS/MS analysis and a pFind 3 blind search to identify unexpected modifications. Using this method, we have discovered non-protein substrates of SUMO, of which spermidine is the major one for fission yeast SUMO Pmt3. Spermidine can be conjugated to the C-terminal carboxylate group of Pmt3 through its N1 or also likely, N8 amino group in the presence of SUMO E1, E2, and ATP. Pmt3-spermidine conjugation does not require E3 and can be reversed by SUMO isopeptidase Ulp1. SUMO-spermidine conjugation is present in mice and humans. Also, spermidine can be conjugated to ubiquitin in vitro by E1 and E2 in the presence of ATP. The above observations suggest that spermidine may be a common small molecule substrate of SUMO and possibly ubiquitin across eukaryotic species.

SUMO’s intrinsically disordered N-terminus is an intramolecular inhibitor of SUMO - SIM interactions

Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation

SUMO Interacting Motifs: Structure and Function

SUMO is a pervasive regulator of meiosis

Structural analysis and evolution of specificity of the SUMO UFD E1-E2 interactions

SUMO and the robustness of cancer

An Atypical Mechanism of SUMOylation of Neurofibromin SecPH Domain Provides New Insights into SUMOylation Site Selection

SUMO conjugation – a mechanistic view

SUMO paralogue–specific functions revealed through systematic analysis of human knockout cell lines and gene expression data

Signalling mechanisms and cellular functions of SUMO

Protein modification by SUMO.

Multifaceted roles of SUMO in DNA metabolism

Characterizing the Conformational Dynamics of Human SUMO2: Insights into its Interaction with Metal Ions and SIMs

SUMO proteases: from cellular functions to disease

NFATC2IP is a mediator of SUMO-dependent genome integrity

Global analysis of protein and small-molecule substrates of ubiquitin-like proteins (UBLs)

Sumoylation Influences DNA Break Repair Partly by Increasing the Solubility of a Conserved End Resection Protein.

Putative Role of Sumoylation in Controlling the Activity of Deubiquitinating Enzymes in Cancer

SUMOylation Homeostasis in Tumorigenesis

DeSUMOylation: An Important Therapeutic Target and Protein Regulatory Event.

SUMO Modification in Apoptosis